|
Effect of Polyunsaturated Fatty Acids on Cardiovascular and Motor Responses Under Stress Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for qualified medical advice, visits or professional assistance by using a real mD. We are not docs. Always confer with your physician about Effect of Polyunsaturated Fatty Acids on Cardiovascular and Motor Responses Under Stress conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Effect of Polyunsaturated Fatty Acids on Cardiovascular and Motor Responses Under Stress Clinical research trials and Effect of Polyunsaturated Fatty Acids on Cardiovascular and Motor Responses Under Stress health trials occur in many of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectivity of new does drugs. The intent of the studies / undertakings is to resolve particular human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to detect remedies for all sorts of conditions, including Effect of Polyunsaturated Fatty Acids on Cardiovascular and Motor Responses Under Stress. Effect of Polyunsaturated Fatty Acids on Cardiovascular and Motor Responses Under Stress Clinical Trials and other clinical trials permit volunteers to obtain healthcare treatment alternatives before they are available to the masses. Most times the participants undergo professional assistance for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a Effect of Polyunsaturated Fatty Acids on Cardiovascular and Motor Responses Under Stress clinical trial. Test subjects typically receive the most expert healthcare available for their Effect of Polyunsaturated Fatty Acids on Cardiovascular and Motor Responses Under Stress condition. Dangers are a reality, however, and may include more or frequent mD visits, healthcare dangers (perhaps life-endangering), and/or the treatment being ineffectual. Trials are federally regulated with rigid guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "E" Clinical Trials Conditions > Effect of Polyunsaturated Fatty Acids on Cardiovascular and Motor Responses Under Stress  Effect of Polyunsaturated Fatty Acids on Cardiovascular and Motor Responses Under Stress
Effect of Polyunsaturated Fatty Acids on Cardiovascular and Motor Responses Under Stress
For Condition: Healthy
Status: Recruiting
Sponsor(s): National Institute on Alcohol Abuse and Alcoholism (NIAAA) ,
Synopsis: This research study is designed to find out if increasing the dietary intake of polyunsaturated fats improves concentration, motor skills and cardiovascular responses under stress. These polyunsaturated fats may also change the chemicals in the brain that control these responses. Specifically, these polyunsaturated fats may raise brain levels of neurotransmitters called dopamine and serotonin. Polyunsaturated fats are important for improving the function of both the brain and the heart. People cannot make these polyunsaturated fats and they can only be obtained from the oils that we eat. For three months subjects will take 8 capsules a day that contain either corn oils flavored with fish oils or fish oil that taste a little like corn oils. Subjects will not be told which oils we expect to work better. An initial evaluation will determine if subjects fit the criteria necessary to enter the study. A battery of tests will be conducted twice, once before starting the capsules and again after three months of taking the capsules. These batteries of tests will include an MRI of the head, paper and pencil tests to evaluate changes in mood, and tests of concentration and motor skills and cardiovascular responses under stress. Two lumbar punctures will be performed to collect cerebrospinal fluid so that changes in neurotransmitters can be evaluated. Subjects will be on a no seafood diet to equalize their dietary intake of polyunsaturated fatty acids. Subjects will be expected to complete all parts of this study.
Details: The central aim of this protocol is to determine if the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic and (DHA) reduce aggressive behaviors among alcoholics in a randomized, double blind, placebo controlled trial. Aggression will be measured in a well-established behavioral test, the Point Subtraction Aggression Paradigm. Secondary and tertiary aims are to determine if supplementation will improve neurochemical mechanisms and cardiovascular abnormalities that are linked to the pathophysiology of aggression. A testing battery will be done before supplementation (baseline) and compared to the same battery repeated after three months of supplementation. This battery will include 1) psychometric measures (aggression, depression and impulsivity), 2) a neurochemical measure (a lumbar puncture for assessment of cerebrospinal fluid 5-hydroxyindolacetic acid [CSF 5-HIAA], a metabolite of serotonin), and 3) a measure of cardiovascular physiology (heart rate variability). The research participants will be randomized to consume four 1-gram capsules/ d containing either 1.88 grams of DHA plus EPA (active) or reference oils containing corn oil and 1% fish oil for flavor blinding (placebo). Research participants will be aggressive alcoholics defined as scoring 20 or more on the Coccaro Lifetime History of Aggression Scale and who eat seafood no more than once per week. If these inexpensive nutrients reduce aggression or the related neurochemical and cardiovascular measures, these findings will be readily applicable to many aggressive populations.
Eligibility:
Study Type: Interventional, Treatment, Safety
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA: A primary diagnosis of alcohol dependence within the last three months. Male or female research participants with a Coccaro Lifetime History of Aggression score of 20 or more. Reported consumption of seafood no greater than twice per week. Age of 18 years or older. Must have been sober for 21-60 days. Laboratory history and physical exam findings that are without significant abnormalities (significant abnormality would include laboratory deviations that require medical intervention or that indicate a major medical disorder). EKG and chest X-ray are without clinically significant abnormalities as determined by the physician interpreting the studies. Educational level and degree of understanding that is sufficient to provide informed consent and to allow for clear and intelligent communication between research participant, investigators and staff. EXCLUSION CRITERIA: Lifetime history of an axis I psychiatric disorders specifically psychotic, schizophrenic, bipolar affective disorder type I or eating disorders or premenstrual phase dysphoric disorder. Major depression, depressive disorder NOS, panic and other anxiety disorders are not exclusionary. Axis II personality disorders are not exclusionary. Major medical disorders or major neurological disorders. Determination by the Principal Investigator that the subject's use of prescription or illicit drugs within the last six months will interfere with the dependent endpoints of the study. Regular use of prescription medications with psychotropic effects including side effects or medications that modify lipid metabolism, within the last month. Use of NSAIDS, aspirin or Tylenol not more than five times total per week, will be allowed. Current psychotherapy to reduce aggression or depression. Extensive use of home remedies, vitamins or nutritional supplements within three months. Use of multi-vitamins one time per day will be allowed. Pacemaker or other metal implants, which might be a contraindication for a MRI, scan. Laboratory tests which indicate presence of the HIV. Pregnancy. Allergy to fish or seafood.
Total Enrollment: 100
Location and Contact Information:
National Institute on Alcohol Abuse and Alcoholism (NIAAA) *Recruiting*
Bethesda, Maryland, 20892
United States
Recruiting Patient and Public Liaison Office 1-800-411-1222
Additional Information:
Study ID Numbers: 010141; 01-AA-0141
Study Start Date: April 4, 2001
Record last reviewed: April 1, 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00014027
Other Healthy Studies:
1. Heterosexual HIV Transmission Study (HATS)
2. Study of Cushing's Syndrome Not Related to ACTH Production
3. Effect of High Levels of Oxygen and Smoking on the Lungs in Human Volunteers
4. Characterizing Serum Protein Patterns in Selected Skin Diseases
5. Study of Brain Blood Flow During Induced Hypercapnia (Excess Blood Carbon Dioxide)
Related Studies:
Other Healthy Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Effect of Polyunsaturated Fatty Acids on Cardiovascular and Motor Responses Under Stress
|
|
|
|
|
|
|
|
